Recombinant porcine interleukin 4, and encoding gene and expression method thereof

A technology of interleukin and expression method, which is applied in the field of expression, purification and inclusion body renaturation, recombinant porcine interleukin 4 and its coding gene, which can solve the problems of precipitation, affecting yield, imperfect processing and modification system, etc.

Active Publication Date: 2013-04-03
GENSUN INST OF BIOMEDICINE
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are still many insurmountable shortcomings in the prokaryotic expression system: for example, the expression time and expression level cannot be regulated, the expression of foreign proteins is toxic to the host cell, and the purification of the product is difficult; in addition, due to the prokaryotic expression system translation The post-processing modification system is not perfect, and the products are mostly produced in the form of inclusion bodies with low biological activity
If the renaturation conditions are not suitable, there will be a mismatch of disulfide bonds in the molecule, and covalent or hydrophobic bonds between molecules will form aggregates, which will reduce the specific activity of the recombinant protein, resulting in unqualified product quality and easy precipitation. , affecting the yield

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant porcine interleukin 4, and encoding gene and expression method thereof
  • Recombinant porcine interleukin 4, and encoding gene and expression method thereof
  • Recombinant porcine interleukin 4, and encoding gene and expression method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0069] Example 1 Recombinant porcine interleukin 4 gene optimization design

[0070] 1. Codon optimization

[0071] There are 64 genetic codes, but most organisms tend to use a subset of these. Those that are most frequently used are called optimal codons, and those that are not frequently used are called rare or low-usage codons. Virtually every organism commonly used for protein expression or production (including E. coli, yeast, mammalian cells, plant cells, and insect cells) exhibits some degree of difference or bias in codon usage. The expression efficiency of genes containing optimal codons in E. coli, yeast and Drosophila was significantly higher than that of genes containing low utilization codons. Therefore, in the heterologous expression system, the codon bias largely affects the expression of recombinant proteins. Gene synthesis using preferred codons and avoiding rare codons is called codon optimization. The optimization process fully takes into account vario...

Embodiment 2

[0094] Embodiment 2: Construction of the expression plasmid of recombinant porcine interleukin 4 gene

[0095] The fragment synthesized from the optimized recombinant porcine interleukin 4 gene (as shown in SEQ ID No: 1) was constructed into the pUC57 plasmid (provided by Nanjing GenScript Co., Ltd.) to obtain a long-term preservation plasmid, Denote as pUC57-prIL4 plasmid. Using the pUC57-prIL4 plasmid as a template, the upstream and downstream primers were respectively introduced into NdeI and XhoI restriction sites for PCR amplification. The sequences of the primers used are as follows:

[0096] Upstream primers:

[0097] P1: GGGAATTCCATATGCATAAGTGTGATATTACGCTGC

[0098] Downstream primers:

[0099] P2: CCGCTCGAGTCAGCATTTGCTGTACTTTTC

[0100] The total volume of the reaction was 50 μL, in which 2.5 μL of each primer was added at a concentration of 10 μmol / L, and 1 μL of dNTP at a concentration of 10 mmol / L was added. The DNA polymerase used was Phusion High-Fidelity D...

Embodiment 3

[0102] Example 3 High expression and identification of recombinant porcine interleukin 4 in Escherichia coli

[0103] Specific steps are as follows:

[0104] 1. The pET21b-prIL4 plasmid with correct sequencing alignment in Example 2 was transformed into a competent strain of Escherichia coli BL21 (DE3) (purchased from Beijing Tiangen Biochemical Technology Co., Ltd.), and cultured overnight on an ampicillin plate at 37°C.

[0105] 2. On the second day, pick 1-4 recombinant colonies containing the pET21b-prIL4 plasmid, insert them into LB medium containing 100 μg / mL ampicillin, and culture them overnight at 37°C.

[0106] 3. Take 50 μL of the overnight culture and insert it into 5 mL of LB induction medium containing 100 μg / mL ampicillin, and culture at 37°C with shaking.

[0107] 4. The OD600 value of the bacterial solution was measured every 1 h after inoculation, and when the OD600=1.0, the expression was induced with 1 mmol / L IPTG (purchased from Amresco). At the sa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a recombinant porcine interleukin 4, and an encoding gene, an expression method, a purification method and an inclusion body renaturation method of the recombinant porcine interleukin 4, and belongs to the field of biological genetic engineering. The interleukin 4 plays an important part in immune regulation in a consequence of disease, thereby being widely used in animal disease treatments. In order to obtain a large amount of porcine interleukin 4, the escherichia coli expression system is used for performing heterologous expression to the recombinant porcine interleukin 4 gene of which the codon is optimized. In addition, because the porcine interleukin 4 in a prokaryotic expression is mostly expressed in form of inclusion body, the invention also provides an inclusion body purification method of the recombinant interleukin 4 and screens the inclusion body renaturation method. Finally, the activity of the recombinant interleukin 4 obtained according to the invention is 5*10<5>IU/ml to 2*10<6> IU/ml and is 2 folds of the activity of the internationally recognized porcine interleukin 4 standard, thus the standard of industrial production is completely achieved.

Description

technical field [0001] The invention belongs to the field of bioengineering genes, and relates to a method for recombinant porcine interleukin 4 and its coding gene, expression, purification and inclusion body renaturation. Background technique [0002] Interleukin 4 (IL-4) is synthesized and secreted by activated T cells, mast cells and basophils. It is a multifunctional lymphokine with a variety of complex biological activities, including the regulation of T lymphocytes. growth, reproduction and differentiation; regulate the differentiation process of T cells stimulated by antigens, so that the differentiated T cells can produce cytokines such as IL-4, IL-5, IL-10 and IL-13. The more important physiological functions of IL-4 also include the ability to control the specificity of immunoglobulin type switching, and human B cells stimulated by IL-4 begin to express IgE and IgG4. The induced response of IL-4 to T cells, B cells and NK cells plays an important immunoregulatory...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/54C07K1/14C12N15/24C12N15/63C12N1/21C12P21/02C12R1/19
Inventor 马永王安良章成昌徐春林陈晨王耀方
Owner GENSUN INST OF BIOMEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products